HC Wainwright Has Weak Outlook for Gossamer Bio Q1 Earnings
Gossamer Bio, Inc. (NASDAQ:GOSS – Free Report) – Stock analysts at HC Wainwright dropped their Q1 2025 earnings estimates for shares of Gossamer Bio in a note issued to investors on Tuesday, March 18th. HC Wainwright analyst P. Trucchio now anticipates that the company will post earnings per share of ($0.16) for the quarter, down […]
